RSVAX
Price
$25.39
Change
+$0.22 (+0.87%)
Updated
Jul 17 closing price
Net Assets
258.84M
VMVIX
Price
$65.67
Change
+$0.51 (+0.78%)
Updated
Jul 17 closing price
Net Assets
30.57B
Interact to see
Advertisement

RSVAX vs VMVIX

Header iconRSVAX vs VMVIX Comparison
Open Charts RSVAX vs VMVIXBanner chart's image
Victory RS Value A
Price$25.39
Change+$0.22 (+0.87%)
VolumeN/A
Net Assets258.84M
Vanguard Mid-Cap Value Index Investor
Price$65.67
Change+$0.51 (+0.78%)
VolumeN/A
Net Assets30.57B
RSVAX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSVAX vs. VMVIX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSVAX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. RSVAX (259M). VMVIX pays higher dividends than RSVAX: VMVIX (2.14) vs RSVAX (0.37). RSVAX was incepted earlier than VMVIX: RSVAX (32 years) vs VMVIX (19 years). RSVAX (1.33) is less costly to investors than VMVIX (0.19). RSVAX is a more actively managed with annual turnover of: 39.00 vs. VMVIX (19.00). RSVAX has a lower initial minimum investment than VMVIX: RSVAX (2500) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 4.95 vs. RSVAX (-5.77). VMVIX return over 5 years is better than : 67.64 vs. RSVAX (27.81).
RSVAXVMVIXRSVAX / VMVIX
Total Expense Ratio1.300.19684%
Annual Report Gross Expense Ratio1.330.19700%
Fund Existence32 years19 years-
Gain YTD1.0032.38042%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets259M30.6B1%
Annual Yield % from dividends0.372.1417%
Returns for 1 year-5.774.95-117%
Returns for 3 years7.1427.9326%
Returns for 5 years27.8167.6441%
Returns for 10 years-22.3985.72-26%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA31.232.81
+9.89%
Palvella Therapeutics Inc
TDACU10.43N/A
N/A
Translational Development Acquisition Corp
ALSN88.92-0.13
-0.15%
Allison Transmission Holdings
EXPI10.19-0.12
-1.16%
eXp World Holdings
NVNI0.34-0.01
-4.12%
Nvni Group Limited